Mark Kao

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial

Daniel S. Ory, Elizabeth A. Ottinger, Nicole Y. Farhat et al. · The Lancet · 2017 · 325 citations · Full text

Medicine, Neurology, Pharmacology +9

Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease

Charles H. Vite, Jessica Bagel, Gary P. Swain et al. · Science Translational Medicine · 2015 · 212 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Effective Antimicrobial Regimens for Use in Humans for Therapy of<i>Bacillus anthracis</i>Infections and Postexposure Prophylaxis

Mark R. Deziel, Henry S. Heine, Arnold Louie et al. · Antimicrobial Agents and Chemotherapy · 2005 · 68 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

The Absorption, Metabolism, and Excretion of the Novel Neuromodulator RWJ-333369 (1,2-Ethanediol, [1-2-Chlorophenyl]-, 2-carbamate, [ S ]-) in Humans

Geert Mannens, Jan Hendrickx, C. G. M. JANSSEN et al. · Drug Metabolism and Disposition · 2006 · 43 citations

Medicine, Pharmacokinetics, Pharmacology +14

Intra-Articular Injection of Tranexamic Acid to Reduce Blood Loss after Total Knee Arthroplasty

Bob Jang, Mark Kao, M. Böhm et al. · Journal of orthopaedic surgery · 2014 · 29 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17